These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8878948)

  • 1. Characterisation of alginates from mucoid strains of Pseudomonas aeruginosa.
    Tatnell PJ; Russell NJ; Govan JR; Gacesa P
    Biochem Soc Trans; 1996 Aug; 24(3):404S. PubMed ID: 8878948
    [No Abstract]   [Full Text] [Related]  

  • 2. Colonisation of cystic fibrosis patients by non-mucoid Pseudomonas aeruginosa--characterisation of the alginate from mucoid variants.
    Tatnell PJ; Russell NJ; Govan JR; Gacesa P
    Biochem Soc Trans; 1996 Aug; 24(3):406S. PubMed ID: 8878950
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression of the Klebsiella pneumoniae alginate lyase gene in Pseudomonas aeruginosa--effect on alginate structure.
    Tatnell PJ; Goldberg JB; Gacesa P
    Biochem Soc Trans; 1996 Aug; 24(3):407S. PubMed ID: 8878951
    [No Abstract]   [Full Text] [Related]  

  • 4. Overexpression of the GDP-mannose dehydrogenase gene from Pseudomonas aeruginosa.
    Tatnell PJ; Russell NJ; Gacesa P
    Biochem Soc Trans; 1996 Aug; 24(3):405S. PubMed ID: 8878949
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemical analysis of alginates from mucoid strains of Pseudomonas aeruginosa.
    Tatnell PJ; Russell NJ; Gacesa P
    Biochem Soc Trans; 1994 Aug; 22(3):310S. PubMed ID: 7821569
    [No Abstract]   [Full Text] [Related]  

  • 6. Mucoid Pseudomonas aeruginosa in cystic fibrosis: signal transduction and histone-like elements in the regulation of bacterial virulence.
    Deretic V; Mohr CD; Martin DW
    Mol Microbiol; 1991 Jul; 5(7):1577-83. PubMed ID: 1943693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis.
    Ulrich M; Beer I; Braitmaier P; Dierkes M; Kummer F; Krismer B; Schumacher U; Gräpler-Mainka U; Riethmüller J; Jensen PØ; Bjarnsholt T; Høiby N; Bellon G; Döring G
    Thorax; 2010 Nov; 65(11):978-84. PubMed ID: 20880875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin.
    Ohman DE; Chakrabarty AM
    Infect Immun; 1982 Aug; 37(2):662-9. PubMed ID: 6811437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa infection in cystic fibrosis: prevent, eradicate or both?
    Eber E; Zach MS
    Thorax; 2010 Oct; 65(10):849-51. PubMed ID: 20861286
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS; Høiby N; Espersen F; Koch C
    Thorax; 1992 Jan; 47(1):6-13. PubMed ID: 1539148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alginate production by the mucoid Pseudomonas aeruginosa associated with cystic fibrosis.
    Gill JF; Deretic V; Chakrabarty AM
    Microbiol Sci; 1987 Oct; 4(10):296-9. PubMed ID: 3155272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetics of exopolysaccharide production by mucoid Pseudomonas aeruginosa.
    Ohman DE
    Eur J Clin Microbiol; 1986 Feb; 5(1):6-10. PubMed ID: 3009178
    [No Abstract]   [Full Text] [Related]  

  • 13. Mucoid conversion by phages of Pseudomonas aeruginosa strains from patients with cystic fibrosis.
    Miller RV; Rubero VJ
    J Clin Microbiol; 1984 May; 19(5):717-9. PubMed ID: 6429192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa infection in cystic fibrosis: biosynthesis of alginate as a virulence factor.
    Roychoudhury S; Zielinski NA; DeVault JD; Kato J; Shinabarger DL; May TB; Maharaj R; Kimbara K; Misra TK; Chakrabarty AM
    Antibiot Chemother (1971); 1991; 44():63-7. PubMed ID: 1801646
    [No Abstract]   [Full Text] [Related]  

  • 15. Intrinsic and environmental mutagenesis drive diversification and persistence of Pseudomonas aeruginosa in chronic lung infections.
    Rodríguez-Rojas A; Oliver A; Blázquez J
    J Infect Dis; 2012 Jan; 205(1):121-7. PubMed ID: 22080096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of serology in predicting Pseudomonas aeruginosa infection in young children with cystic fibrosis.
    Douglas TA; Brennan S; Berry L; Winfield K; Wainwright CE; Grimwood K; Stick SM; Sly PD;
    Thorax; 2010 Nov; 65(11):985-90. PubMed ID: 20889526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis.
    Gómez MI; Prince A
    Curr Opin Pharmacol; 2007 Jun; 7(3):244-51. PubMed ID: 17418640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS
    APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis.
    Pier GB; Coleman F; Grout M; Franklin M; Ohman DE
    Infect Immun; 2001 Mar; 69(3):1895-901. PubMed ID: 11179370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients.
    Poschet JF; Boucher JC; Firoved AM; Deretic V
    Methods Enzymol; 2001; 336():65-76. PubMed ID: 11398420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.